We are a hands-on investor taking leading positions and understanding the balance between finance, commercial assets and people.

For almost twenty years, the partners of Aravis have invested in innovative and scalable high-tech companies and have deployed over USD 400 million through four funds. All four Aravis partners have very international and complementary backgrounds and have used their …
For almost twenty years, the partners of Aravis have invested in innovative and scalable high-tech companies and have deployed over USD 400 million through four funds. All four Aravis partners have very international and complementary backgrounds and have used their technological know-how to scale a company from cradle to exit. Our purpose is to add more value than just money, we strive to support and guide entrepreneurs in pursuit of their visions..

Are you looking for a lead investor who can syndicate a larger financing round? Do you need to build up a human resources department which helps your people to grow? Would you like to meet your growth investor before you raise money to save your time for essential things when you need the investment? Are you looking for a head of sales who can help you expand your market? We'd love to help.

- We are a private equity firm located in Zurich, Switzerland and have sponsored multiple fund vintages since our founding in 2001.
- We primarily focus on high-tech growth investments.
- Our core competence is to enable technology to scale up companies.
- We have a diverse group of limited partners consisting of pension funds, charitable foundations, family offices, fund managers and corporate strategic investors.
- Our investment professionals are experienced, curious, creative, dedicated and well-networked. Our goal is to support and guide entrepreneurs to pursue their company vision.


Growth I
Aravis Growth is a new initiative. With a strong focus on growth funding in Switzerland we will build a portfolio in the sectors of Biotech, Creative and Digital as well as Industrial High Tech. Actively accelerating the best companies to…

Aravis Growth is a new initiative. With a strong focus on growth funding in Switzerland we will build a portfolio in the sectors of Biotech, Creative and Digital as well as Industrial High Tech. Actively accelerating the best companies to international success and making use of years of experience, our team will fill an important gap in the Swiss market.
Team: Jean-Philippe Tripet, Emmanuel Savioz, Jan Reinhart, Claudia Zimmermann, TBA

Aravis Growth

Aravis SA founded

Aravis SA was founded in 2001 by Jean-Philippe Tripet after a successful international career at UBS and Lombard Odier.


Aravis is managed and advised by an international team of industrial
and private equity experts.
Jean-Philippe Tripet

Jean-Philippe Tripet

lic.oec, CFA

Founder and Chairman

Venture / Growth

During his career, Jean-Philippe has led and supervised over 100 investments in private companies worldwide.He has been active in Private Equity since 1994.

He is a member of the Steering Committee of the Swiss Entrepreneurs Foundation. He is also a member of the Advisory committee on Digital Transformation for the Swiss Government.

Prior to founding Aravis, he was a Senior Executive Vice-President and member of the Group Executive Committee at Lombard Odier & Cie, Geneva. Before that, he was vice-President, Equity Research at UBS in Zurich and London.

He has a degree in business administration from the University of Geneva, did graduate studies in finance in San Diego, California and is a Chartered Financial Analyst since 1993. He lectures at the University of Lugano.(USI)

Emmanuel Savioz

Emmanuel Savioz


Managing Partner

Corporate Finance, Entrepreneur

Emmanuel Savioz is co-founder of several Biotech and industrial companies in Switzerland. He is a board member of HYT, Preciflex, Phi Pharma, TOLREMO therapeutics, and MirroSpace.

Prior to this, he was the CFO of HYT, Preciflex, Phi Pharma, TOLREMO therapeutics and Virometix. He was also responsible for M&A projects at Lehman Brothers and Goldman Sachs in New York and Paris, as well as at RJR Nabisco Holdings in New York

Moreover he has set up companies in South Korea, Singapore and Malaysia. In addition he worked on multibillion dollars deals before cofounding several start-ups, leading them through growth phases and helping them raise significant sums in equity

He holds a Masters degree in business administration from the University of California, Berkeley.

Jan Reinhart

Jan Reinhart

MBA(Harvard), MS(ETH Zurich)

Managing Partner

Information Technology/Digital

Jan Reinhart is the owner of Reinhart Capital, a Swiss company focusing on venture capital in IT companies.

During his career, Jan has performed and participated in over 70 investments in Europe and the US. He co-founded and recently sold his block-chain bank PayCash to Daimler AG.

Prior to founding his own companies, he was recruited by the CEO of Swisscom to build the Swisscom Venture Fund. Before this he was the VP of Marketing and Business development Innopath Software in Sunnyvale, California and  also spent 6 years as a direct report for new businesses to the SAP’s Chairman, CEO and co-founder, Hasso Plattner in Palo Alto California. He was also Senior Consultant at Nestlé in France, USA, Mexico and Nigeria

He graduated with an MBA from Harvard Business School and with an MS in Mechanical Engineering from ETH Zurich.




Claudia Zimmermann

Claudia Zimmermann

Economist SEBA, CFA

Managing Partner

CFO Industry

Claudia Zimmermann is also the founder and CEO of C-Advisory GmbH, an advisory firm to support sustainable growth for companies. She is on the BoD of ADEV Energiegenossenschaft, Vice President of the Board of ADEV Wasserkraftwerke AG and a Juror of Venture.ch.

Before founding C-Advisory, she was the CFO of the Noser Group, an internationally operating Swiss-based ICT-Group. She gathered profound experience as a consultant with PwC Valuation & Strategy in Infrastructure, Utilities & Transportation and the Public Sector (e.g. PPPs). Claudia started her career with industrial companies (Rieter, ABB) and worked or studied in various countries around the globe.

She holds a degree as Economist SEBA, is a CFA-Charterholder and holds a CAS Applied History of the University of Zurich. She attended Executive Programs at Harvard Business School, IMD and various expert seminars.


Ursula Rüegsegger

Ursula Rüegsegger


Board Member

CEO Industry

Ursula Rüegsegger is the CEO of Sanacare AG, an ambulatory care provider with doctor’s offices at 13 different sites across Switzerland.


Prior to leading Sanacare she was General Manager Switzerland of Baxter. She has over 15 years of international and national strategic consulting and execution experience in Life Sciences resulting from leadership positions in large and mid-sized companies as well as 7 years at McKinsey & Company. Leveraging her experience, she advises investors and mentors entrepreneurs of start-up and SME companies with a focus on the healthcare and life science sector.


Ursula is a biochemist with a PhD and a postdoctoral degree from the University of Basel and the University of California at San Francisco, respectively.



Martin Eisenring

Martin Eisenring

Dr. iur.

Legal and Compliance, Secretary of the Board

Legal and Compliance

Martin Eisenring works as an independent Attorney-at-law & Notary Public in Zug.

Before founding his own law firm he was a managing partner of the Zug office of one of the leading Swiss business law firms. He also gathered experience in the area of shareholder activism with a Geneva based investment foundation. He has many years of consultancy experience in the broad areas of business law, with his main focus being in the fields of corporate law, commodity trading, private equity and pension funds.

He studied law at the University of Fribourg and received his PhD (Dr. iur.) from the University of Zurich. Furthermore, he holds an executive diploma from the University of St. Gallen and the Certificate of Advance Studies (CAS) from the University of Lucerne

Evangeline de Macedo

Evangeline de Macedo

PA to Chairman


Evangeline de Macedo undertakes all the administration and personnel duties of Aravis and is the PA to Jean-Philippe Tripet.

Prior to this she first worked for the Export Service Zentrum in Arnhem, Netherlands as a market research analyst before joining Singapore Airlines, where she oversaw the functions of accounting departments in Singapore, Germany and Switzerland. She was also employed by the Singapore Tourism Board in Zurich as well as the British Swiss Chamber of Commerce to perform administration and accounting functions.

Evangeline holds an Honors degree in Business Administration from the National University of Singapore.

Margaretha Bruelisauer

Margaretha Bruelisauer



Margaretha Bruelisauer is responsible for the accounting functions.

Prior to joining Aravis, she worked for several auditing and accounting companies in Zürich.

She has a Federal Certificate in accounting.

Léna Tripet

Léna Tripet



Léna Tripet was a Risk and Insurance Management trainee at Gategroup and Symetis SA, where she did data analysis and developed key performance indicators.

She holds a Masters degree in International Finance Management at the Hochschule Luzern and a Bachelors degree from ZHAW, School of Management and Law. She did a one year student exchange study at Montreal University in Quebec.

She is also a Young SECA member and coaches at Venturelab.

Simon Nebel

Simon Nebel


Venture Partner


Simon Nebel has participated in the financing in a number of life science companies and the M&A transactions for Aravis portfolio companies. He was a co-founder of Aravis Energy I LP, the first Swiss Limited Partnership focused on renewable energy. Simon has been board member or observer in fourteen companies and is currently board member of SynAffix (NL), MarinoMed (AT), Bird Rock Bio (La Jolla/USA)) and BioSilu Healthcare (DE).

Before joining Aravis, he was a group strategist at UBS (London, Basel and Zurich), where he coordinated and worked on business planning and modelling, including developing a Biotechnology Venture Capital proposal for UBS Capital.

He holds a PhD in Biophysics from the Biocentre of the University of Basel (1996) and an MBA with distinction from the London Business School (2001).


Since the creation of aravis we have been actively partnering with all our companies. We look for entrepreneurs with a vision, teams who want to transform life and business. Our aravis partners will invest time, talent and experise. We will provide strategic advice, domain expertise and capital to help realise and accelerate growth.
Status: All Current Exited
Sector: All Growth Biotech Energy Luxury


Aravis is the first independent firm to have filed a Swiss onshore Limited partnership with FINMA. The administration team has built a reliable accounting, investment valuation, compliance, reporting and administrative experience. Since 2008, we have successfully received approval for 4 different partnerships. This collective expertise forms a platform that Aravis offers to external partners. If you are interested in hearing more about how Aravis could help, please contact us at info@aravis.ch.


Merkurstrasse 70
CH-8032 Zurich

Our websites uses Google Analytics and cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our privacy statement.
Accept Decline Google Analytics tracking on this website